In the Senescence Accelerated Mouse‐Prone 8 (SAMP8) mouse, an Alzheimer's disease mouse model, GSK‐3β inhibition caused NRF2 activation and decreased oxidative stress, together with reduced Tau phosphorylation and improved learning and memory (Farr et al, 2014). Here, MAPT is linked to Alzheimer disease.